The initial evaluation of potential hepatic damage in pediatric COVID-19 shall include AST/ALT, GGT, ALP, Ammonia, Bilirubin, lactate dehydrogenage (LDH), creatinine phosphokinase (CPK), d-dimer, C-reactive protein (CRP) and ferritin evaluations on Intensive Care Unit (ICU) admission. This evidence concerns the gene GPT and COVID-19.